AR061309A1 - Uso antiviral de un tensioactivo cationico - Google Patents

Uso antiviral de un tensioactivo cationico

Info

Publication number
AR061309A1
AR061309A1 ARP070102512A ARP070102512A AR061309A1 AR 061309 A1 AR061309 A1 AR 061309A1 AR P070102512 A ARP070102512 A AR P070102512A AR P070102512 A ARP070102512 A AR P070102512A AR 061309 A1 AR061309 A1 AR 061309A1
Authority
AR
Argentina
Prior art keywords
derived
acid
lae
cultures
condensation
Prior art date
Application number
ARP070102512A
Other languages
English (en)
Inventor
Pons Roger Segret
Bonvila Xavier Rocabayera
Roca Sergi Figueras
Original Assignee
Miret Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37728271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR061309(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Miret Lab filed Critical Miret Lab
Publication of AR061309A1 publication Critical patent/AR061309A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Los tensioactivos cationicos derivados de la condensacion de ácidos grasos y aminoácidos dibásicos esterificados, tal como el proveniente del ácido Iaurico y la arginina, en particular el éster etílico de la lauramida del monohidrocloruro de la arginina (LAE), puede ser usado para la proteccion contra el crecimiento de microorganismos. Los tensioactivos cationicos de este tipo son también efectivos contra las infecciones virales. El anadido de LAE a cultivos de Herpes virus tipo 1, virus de Vaccinia y virus de la parainfluenza bovina 3 conduce a una reduccion completa en una etapa temprana de los organismos virales en dichos cultivos, tales efectos comienzan a ser observados luego de 5 y 60 minutos. Reivindicacion 1: Uso de un tensioactivo cationico derivado de la condensacion de ácidos grasos y aminoácidos dibásicos esterificados, segun la siguiente formula (1) donde X- es Br-, CL-, HSO-4, un ion de signo contrario derivado de un ácido orgánico o inorgánico, o un anion en base a un compuesto fenolico; R1 es un alquilo de cadena lineal proveniente de un ácido graso saturado o hidroxiácido de C8-14 unido al grupo alfa-amino a través de una union amídica; R2: es un alquilo de cadena lineal o ramificada de C1-18 o un grupo aromático; R3 es como se muestra en las formulas (2) y n puede ser un numero entero de 0 a 4, para el tratamiento de infecciones virales.
ARP070102512A 2006-08-03 2007-06-08 Uso antiviral de un tensioactivo cationico AR061309A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2006/065035 WO2008014824A1 (en) 2006-08-03 2006-08-03 Antiviral use of cationic surfactant

Publications (1)

Publication Number Publication Date
AR061309A1 true AR061309A1 (es) 2008-08-20

Family

ID=37728271

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102512A AR061309A1 (es) 2006-08-03 2007-06-08 Uso antiviral de un tensioactivo cationico

Country Status (13)

Country Link
EP (1) EP2046316B1 (es)
JP (1) JP2009545541A (es)
CN (1) CN101500552A (es)
AR (1) AR061309A1 (es)
AT (1) ATE482697T1 (es)
AU (1) AU2006346933A1 (es)
BR (1) BRPI0621922A2 (es)
CA (1) CA2658446A1 (es)
DE (1) DE602006017272D1 (es)
ES (1) ES2353726T3 (es)
IL (1) IL196583A0 (es)
MX (1) MX2009001200A (es)
WO (1) WO2008014824A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8795638B1 (en) 2003-08-26 2014-08-05 Nevada Naturals Inc. Compositions for dental care
US8193244B1 (en) 2008-05-29 2012-06-05 Nevada Naturals, Inc. Antimicrobial agents
US8926997B1 (en) 2003-02-06 2015-01-06 Richard F. Stockel Polymeric biocidal salts
US9023891B2 (en) 2008-05-29 2015-05-05 Nevada Naturals, Inc. Synergistic antimicrobial agents
ES2392384T3 (es) * 2008-07-02 2012-12-10 Laboratorios Miret, S.A. Uso de tensioactivos catiónicos como agentes esporicidas
CH701769A1 (de) 2009-09-08 2011-03-15 Schoeller Textil Ag Wiederbeladbare Ausrüstungen für Textilien und Formulierungen zur Beladung solcher Ausrüstungen.
WO2011105633A1 (en) 2010-02-26 2011-09-01 Ajinomoto Co., Inc. Virus-inactivating composition containing low-molecular weight compound and arginine
US8834857B1 (en) 2011-01-18 2014-09-16 Nevada Naturals Inc. Deodorizing and skin cleaning
WO2013103556A1 (en) * 2012-01-05 2013-07-11 The Trustees Of Columbia University In The City Of New York Antimicrobial composition
US20180228749A1 (en) * 2016-06-28 2018-08-16 Mehmet Nevzat Pisak Surfactants and compositions for treatment of viral skin conditions
CN108813166B (zh) * 2017-11-03 2022-06-07 华东师范大学 月桂酰精氨酸乙酯衍生物作为饲料营养能量物质的用途
CN113797189A (zh) * 2017-11-03 2021-12-17 华东师范大学 月桂酰精氨酸乙酯衍生物和作为动物用抗菌剂的用途
CN108740356B (zh) * 2017-11-03 2022-10-25 华东师范大学 月桂酰精氨酸乙酯衍生物作为饲料添加剂的用途
CN110317684B (zh) * 2018-06-22 2021-05-25 华东师范大学 天然环保无毒的厨房油污清洗剂
CN110313487B (zh) * 2018-06-22 2021-07-27 华东师范大学 新型皮革防霉护理剂及其制备方法和应用
CN110235899B (zh) * 2018-06-22 2022-04-05 华东师范大学 新的食品防腐剂及其制备方法和应用
CN112790196B (zh) * 2018-06-22 2022-05-06 华东师范大学 防腐杀菌型湿巾及其制备方法和应用
CN110302192A (zh) * 2018-06-22 2019-10-08 华东师范大学 新的抗微生物组合物及其制备方法和应用
CN114869792A (zh) * 2018-06-22 2022-08-09 华东师范大学 新的口腔护理组合物及其制备方法和应用
CN110314108A (zh) * 2018-06-22 2019-10-11 华东师范大学 新的洗浴用品组合物及其制备方法和应用
CN110313488B (zh) * 2018-06-22 2021-07-27 华东师范大学 防霉型粘合剂及其制备方法和应用
CN112107566A (zh) * 2019-06-21 2020-12-22 华东师范大学 月桂酰精氨酸乙酯及其衍生物作为抗病毒剂的用途
US20210330701A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers and surfactant
JP2023540466A (ja) * 2020-08-31 2023-09-25 サルバシオン ユーエスエー インコーポレイテツド 抗ウイルス組成物及びその使用法
EP4114381A2 (en) 2020-12-08 2023-01-11 Laboratorios Miret, S.A. Cationic surfactants, in particular ethyl lauroyl arginate lae®, for treating or preventing infections and contaminations with coronavirus
CN114681628A (zh) * 2022-01-24 2022-07-01 抚顺东科新能源科技有限公司 一种温和无刺激医用超声凝胶及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53118516A (en) * 1977-03-24 1978-10-17 Ajinomoto Co Inc Inactivation disinfectant of hepatitis-b virus
JPS5645402A (en) * 1979-09-21 1981-04-25 Ajinomoto Co Inc Disinfectant inactivating hepatitis virus b
CA2455981C (en) * 2001-08-09 2012-10-09 Joan Baptista Urgell Beltran Use of cationic surfactants in cosmetic preparations
US7407679B2 (en) * 2001-10-25 2008-08-05 Laboratorios Miret, S.A. Use of cationic preservative in food products
BR0116767A (pt) * 2001-11-15 2003-12-23 Miret Lab Uso de tensoativo catiÈnico como acentuador de atividade em desodorantes e cuidado oral
US20060264347A1 (en) * 2005-05-19 2006-11-23 Xintian Ming Antimicrobial composition

Also Published As

Publication number Publication date
MX2009001200A (es) 2009-02-11
CA2658446A1 (en) 2008-02-07
EP2046316B1 (en) 2010-09-29
CN101500552A (zh) 2009-08-05
WO2008014824A1 (en) 2008-02-07
ATE482697T1 (de) 2010-10-15
DE602006017272D1 (de) 2010-11-11
ES2353726T3 (es) 2011-03-04
AU2006346933A1 (en) 2008-02-07
EP2046316A1 (en) 2009-04-15
BRPI0621922A2 (pt) 2011-12-20
IL196583A0 (en) 2009-11-18
JP2009545541A (ja) 2009-12-24

Similar Documents

Publication Publication Date Title
AR061309A1 (es) Uso antiviral de un tensioactivo cationico
UY30485A1 (es) Uso antiviral de un tensioactivo cationico
AR072462A1 (es) Uso de surfactantes cationicos como agentes esporicidas
AR073808A1 (es) Monomeros de carbamato-metacrilato, sus usos en aplicaciones dentales y procesos para su preparacion.
UY30527A1 (es) Tetrazolilos macrociclicos como inhibidores de serina proteasa de hepatitis c
ATE536170T1 (de) Verwendung von kationischen tensiden in kosmetischen mitteln
CO6220906A2 (es) Surfactantes de alquilamidopropil dialquilamina como adyuvantes
AR061238A1 (es) Compuestos de oxilmilo macrociclico inhibidores de proteasa de hepatitis c
ECSP077649A (es) Piridazinonilos macrociclicos como inhibidores de serina proteasa de hepatitis c
ECSP045243A (es) Péptidos macrocíclicos activos contra el virus de la hepatitis C
RU2008129096A (ru) Композиция для лечения волос
AR061054A1 (es) Compuestos acidos de glicerilo y glicol
UY30391A1 (es) Compuesto de oximilo aciclico inhibidores de proteasa de hepatitis c
IL208697A0 (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
BR0313876A (pt) Uso de uma mistura, composições de combustìvel e de solvente, e, processo para a preparação de uma mistura
AR079732A1 (es) Amidas, uso de amidas como solventes para compuestos organicos, composiciones y emulsiones que contienen amidas, y metodo de elaboracion
AR087331A1 (es) Composiciones concentradas de agentes tensioactivos basados en acilamido graso
AR116996A1 (es) Mezclas y composiciones que comprenden 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2-ona, y métodos de uso de las mismas
ES2422593T3 (es) Método y uso de una composición para lavavajillas
AR012323A1 (es) Uso de compuestos de esteresaminas alcoxiladas o de formas cuaternizadas o protonizadas o de mezclas de los mismos en formulaciones establessuavizantes, detergentes, de limpieza o para la higiene personal y procedimiento para preparar composiciones de aplicacion en el uso mencionado
AR011085A1 (es) Composiciones detergentes liquidas, acuosas con estabilidad fisica a baja temperatura; metodo para lavar platos, uso de surfactantes en la composicion
AR037700A1 (es) Un agente suavizante activo
CO6170342A2 (es) Quelatos metalicos con radical peg perfluorado metodo para su preparcion y su uso
WO2022122627A3 (en) Cationic surfactants, in particular ethyl lauroyl arginate lae®, for treating or preventing infections and contaminations with coronavirus
AR068619A1 (es) Composicion solida que consta de un fungicida polienico y al menos un tensioactivo cationico, metodo para preparar la dispersion de un fungicida polienico, una solucion acuosa obtenible segun este metodo y uso de dicha solucion acuosa

Legal Events

Date Code Title Description
FA Abandonment or withdrawal